Back to Search
Start Over
Fulminant Acute Respiratory Distress Syndrome After Calcineurin Inhibitor-belatacept Conversion in a Lung Transplant Recipient
- Source :
- Transplantation. 102:e255-e256
- Publication Year :
- 2018
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2018.
-
Abstract
- Belatacept is increasingly used in lung transplant (LTx) recipients intolerant to calcineurin inhibitors (CNIs), with satisfactory outcome.1 We describe a case of fatal acute respiratory distress syndrome (ARDS) that developed in a single LTx recipient after starting a belatacept-based immunosuppres
- Subjects :
- Graft Rejection
ARDS
medicine.medical_specialty
medicine.medical_treatment
Fulminant
Calcineurin Inhibitors
Drug Resistance
030230 surgery
Belatacept
Gastroenterology
Tacrolimus
Abatacept
03 medical and health sciences
Fatal Outcome
0302 clinical medicine
Risk Factors
Internal medicine
medicine
Humans
Lung transplantation
Aged
Respiratory Distress Syndrome
Transplantation
Lung
Drug Substitution
business.industry
medicine.disease
Calcineurin
medicine.anatomical_structure
Female
030211 gastroenterology & hepatology
business
Immunosuppressive Agents
Lung Transplantation
medicine.drug
Subjects
Details
- ISSN :
- 00411337
- Volume :
- 102
- Database :
- OpenAIRE
- Journal :
- Transplantation
- Accession number :
- edsair.doi.dedup.....54925000ab035f2ab11689210681e90a